ACSF2 is a mitochondrial enzyme that exhibits medium-chain fatty acid-CoA ligase activity . This means it has a preference for medium-chain fatty acids as substrates. The enzyme’s primary function is to activate fatty acids by converting them into acyl-CoA, which can then enter various metabolic pathways, including β-oxidation and lipid biosynthesis .
Mutations or dysregulation of the ACSF2 gene can have significant implications for human health. For instance, abnormalities in fatty acid metabolism can lead to metabolic disorders, including obesity, diabetes, and fatty liver disease. Additionally, ACSF2 has been implicated in the differentiation of adipocytes, the cells responsible for storing fat .
Given its central role in fatty acid metabolism, ACSF2 is a potential target for therapeutic interventions aimed at treating metabolic disorders. Research is ongoing to better understand the enzyme’s function and regulation, which could lead to the development of novel treatments for conditions related to fatty acid metabolism .